secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUIC Worldwide Holdings Ltd. (SUIC)
CIK:        0001394108
Form:       8-K
Filed at:   2026-07-10T18:16:42+00:00
Accession:  0001477932-26-004250
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SUIC Worldwide acquires 51% of Vision Renu in stock-for-stock deal; new CEO and CFO appointed
--------------------------------------------------------------------------------

- SUIC issued 30M shares (35% of fully diluted) to acquire 51% of Vision Renu Corporation.
- Vision Renu develops medical devices: scleral laser for presbyopia (FDA certification ongoing) and TMS for depression (Taiwan approved).
- Board and management overhaul: Harriette Lo, Han Wei Wang, Yee Wei Tan resigned; Chen King Te appointed Chairman/CEO, Shan Hua Peng as CFO.
- Vision Renu has 7 employees, secured 150 unit orders in Taiwan for 2026, targeting 500+ units in 2027.
- Audited financials for Vision Renu for 2024 and 2025 filed as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394108/000147793226004250/0001477932-26-004250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394108/000147793226004250/suic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-004250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer